Yes, discontinue DHEA supplementation immediately when testosterone and estradiol levels are elevated.
When DHEA supplementation results in elevated testosterone and estradiol levels, the supplement should be stopped to avoid potential adverse effects from supraphysiological hormone concentrations.
Clinical Reasoning
The evidence clearly indicates that DHEA supplementation significantly increases both testosterone and estradiol levels, and monitoring is essential to prevent overtreatment:
Evidence for Hormone Elevation with DHEA
DHEA substantially increases sex hormone levels: Meta-analyses demonstrate that DHEA supplementation at doses ≥50 mg/day significantly elevates testosterone (WMD: 24.31-29.65 ng/dL) and estradiol (WMD: 7.02-8.65 pg/mL) in postmenopausal women 1, 2.
Dose-dependent effects: Research shows DHEA at 50 mg/day produces progressive increases in testosterone, dihydrotestosterone, estradiol, and estrone starting from the first month of treatment 3. Even lower doses (10 mg/day) significantly raise androgen levels 4.
Guideline-Based Monitoring Requirements
The Endocrine Society Clinical Practice Guidelines provide clear direction on DHEA monitoring 5:
Target range: DHEA replacement should aim for mid-normal range DHEAS levels, measured via morning serum samples before the daily dose 5.
Monitoring schedule: Assess for signs of androgen excess with serum testosterone levels every 6 months to screen for overuse 6.
Discontinuation criteria: If no sustained beneficial effect occurs after 6 months, DHEA should be discontinued 5.
Risks of Elevated Sex Hormones
Supraphysiological testosterone and estradiol concentrations pose several risks:
The Global Consensus Statement on testosterone therapy explicitly states that preparations resulting in supraphysiologic testosterone concentrations "are not recommended" 6.
Elevated androgens can cause virilization symptoms including hirsutism, acne, voice deepening, and clitoral enlargement.
Elevated estradiol increases risks of endometrial hyperplasia, breast tenderness, and potentially thrombotic events.
Animal studies show DHEA can produce supraphysiological androgen levels in certain tissues (liver showed +536% DHT increase), raising concerns about uncontrolled use 7.
Practical Management Algorithm
When you identify elevated testosterone and estradiol on DHEA:
Immediately discontinue DHEA supplementation - Do not attempt dose reduction; stop completely.
Recheck hormone levels in 4-6 weeks after discontinuation to confirm normalization, as sex steroid levels should return toward baseline within weeks to months.
Assess for clinical signs of androgen excess: hirsutism progression, acne worsening, voice changes, clitoral enlargement, male-pattern hair loss.
Evaluate the original indication: DHEA is only suggested for women with primary adrenal insufficiency (PAI) who have low libido, depressive symptoms, or low energy despite optimized glucocorticoid/mineralocorticoid replacement 5.
If DHEA was being used off-label (not for PAI): Do not restart. The evidence for DHEA benefit outside PAI is insufficient, with systematic reviews showing no substantial clinical benefit 5.
If DHEA was appropriate for PAI: Consider restarting at a lower dose (25 mg instead of 50 mg) only after hormone normalization, with closer monitoring.
Critical Caveats
DHEA is not FDA-approved for most uses: It's available over-the-counter as a supplement, leading to unmonitored use and potential overdosing 5.
Individual variation is substantial: Some women convert DHEA to sex steroids more efficiently than others, making standardized dosing problematic 4, 3.
Context matters for interpretation: If the patient is postmenopausal without PAI, any DHEA use is off-label and not evidence-based. The elevated hormones represent clear overtreatment 6, 8.
Compounded preparations are problematic: Compounded "bioidentical" DHEA cannot be recommended due to lack of quality control and standardization 6.
The bottom line: Elevated testosterone and estradiol on DHEA supplementation indicates excessive dosing and requires immediate discontinuation to prevent adverse effects from hormone excess.